A nationwide shortage of the asthma medication albuterol has been ongoing since last fall and experts fear it's only expected to get worse. Albuterol can be taken in several forms but it's the ...
A nationwide shortage of the asthma medication albuterol has been ongoing since last fall and experts fear it's only expected to get worse. Albuterol can be taken in several forms but it's the ...
The affected lots are as follows: Lot# A3A33A, A3A33B, A3A34A, A3A35A, A3A36A, A3A37A, A3A38A, A3A40A, A3A41A, and A3A42A. All of the affected lots had passed Nephron’s quality specifications at the ...
January 3, 2011 — Ritedose is voluntarily recalling 0.083% albuterol sulfate inhalation solution in 3-mL single-use dose vials because some vials are embossed with incorrect concentration information, ...
COLUMBIA, S.C., May 20, 2025 /PRNewswire/ -- Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the largest sterile contract development manufacturing organization (CDMO) in ...
In a March 8 Twitter thread, the FDA acknowledged it’s aware of a potential drug supply disruption after Gurnee, Ill.-based Akorn Operating Co. closed in late February. The FDA clarified that the ...
Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml). "Driven by the ...
The sudden closure last week of a Gurnee-based pharmaceutical company may prolong shortages of treatments for RSV and asthma. Akorn, which operated manufacturing plants in Decatur, New York and New ...
Orlando, Florida-based Nephron Pharmaceuticals Corp (NPC) has initiated a voluntary recall at the retail level of 10 lots of albuterol sulfate inhalation solution, 0.083%. The recall affects albuterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback